Skip to main content
TipRanks
Go Ultimate75% OFF

Blum Holdings (BLMH) AI Stock Analysis

729 Followers
BLMH

Blum Holdings

(Other OTC:BLMH)

Select Model
Rating:39Underperform
Price Target:$0.14▼(-5.59% Downside)
Action:reiterated
Date:10/24/26

BLMH scores near the bottom of the range, driven primarily by a highly distressed financial profile: a roughly 70% revenue decline from 2022, deeply negative operating margins, a TTM net loss equal to about 62% of sales, negative shareholders' equity of -$11.0M, and continued cash burn that leaves the company reliant on outside financing. Technicals reinforce the caution, with the stock below all key moving averages and negative MACD momentum amid very high volatility (beta 2.29). Valuation provides no offset given negative earnings and no dividend. The credible positives — gross margin improvement to about 44%, debt reduced from $79.4M to $7.9M, and a sharply lower cash burn — show management is stabilizing the business, but until sustained revenue growth and positive operating cash flow emerge, the risk of further dilution or liquidity strain dominates.

Positive Factors
Gross MarginA gross margin near 44% indicates the company retains meaningful value after direct costs, providing a foundation for operating improvement if revenue stabilizes and expenses are controlled. This gives management an existing economic base from which to pursue better profitability over the next several quarters.
Negative Factors
Severe Operating LossesLarge operating and net losses show that the current business model is not converting revenue into sustainable earnings. Persistent losses can consume capital, restrict reinvestment, and make a return to profitability dependent on substantial cost reductions or renewed revenue growth.

Blum Holdings (BLMH) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%BLMH-77.66%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.93M
Dividend Yield
―
Average Volume (3M)
4,868
Price to Earnings (P/E)
-0.4
Beta (1Y)
2.36
Revenue Growth
19.98%
EPS Growth
-180.06%
Country
US
Employees
133
Sector
Healthcare
Sector Strength
51
Industry
Specialty Retail

Blum Holdings Business Overview & Revenue Model

Company Description

Blum Holdings, Inc. is an entity operating within California's regulated cannabis market, comprehensively addressing both medical and adult-use demands. The company's multifaceted involvement encompasses the cultivation, production, distribution, and...

Blum Holdings Financial Statement Overview

Summary

Severely distressed financial profile. Revenue has collapsed roughly 70% from its 2022 peak to $15.8M TTM, operating margins are around -48%, and the TTM net loss of $9.4M equals about 62% of sales. Shareholders' equity is negative at -$11.0M and widening, making solvency and dilution risk elevated. Operating and free cash flow remain negative (-$2.4M and -$2.5M), with losses being largely cash losses. The 2024 'profit' was driven by one-time non-operating gains rather than operations. Offsetting positives are incremental: gross margin has improved to roughly 44%, total debt has been cut from $79.4M to $7.9M, cash burn has shrunk dramatically from -$21.9M in 2021, and revenue has stabilized modestly over the last two periods.

Income Statement

13Very Negative

Balance Sheet

15Very Negative

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Mar 2024Dec 2022Mar 2022
Income Statement
Total Revenue15.76M14.91M12.99M33.23M52.02M42.12M
Gross Profit6.59M6.00M6.21M14.00M16.90M11.02M
EBITDA-6.31M-6.30M22.00M-2.26M-180.51M-30.07M
Net Income-9.39M-7.96M33.10M-14.13M-188.93M-31.27M
Balance Sheet
Total Assets43.57M44.52M24.82M32.07M40.51M271.82M
Cash, Cash Equivalents and Short-Term Investments590.00K813.00K1.04M862.00K1.20M6.70M
Total Debt7.94M7.50M4.79M37.70M49.56M79.41M
Total Liabilities51.67M48.74M29.56M77.77M77.05M125.34M
Stockholders Equity-11.05M-7.17M-6.75M-45.70M-36.54M142.63M
Cash Flow
Free Cash Flow-2.45M-2.53M-2.15M-1.29M-9.76M-21.93M
Operating Cash Flow-2.43M-2.50M-2.14M-965.00K-7.83M-17.96M
Investing Cash Flow65.00K-971.00K2.03M462.00K19.61M21.67M
Financing Cash Flow2.59M3.25M143.00K539.00K-17.27M4.50M

Blum Holdings Technical Analysis

Technical Analysis SentimentNegative
Last Price0.14

Price Trends

50DMA0.18Negative
100DMA0.19Negative
200DMA0.22Negative

Market Momentum

MACD-0.01Positive
RSI42.05Neutral
STOCH5.65Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLMH, the sentiment is Negative. The current price of 0.14 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.18, and below the 200-day MA of 0.22, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 42.05 is Neutral, neither overbought nor oversold. The STOCH value of 5.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BLMH.

Blum Holdings Risk Analysis

Blum Holdings disclosed 56 risk factors in its most recent earnings report. Blum Holdings reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.The Company's subsidiaries, Unrivaled Brands, Inc. and Halladay Holding, LLC, have filed a petition under Chapter 11 of the Bankruptcy Code. Risks and uncertainties related to this filing could have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.Q4, 2024
2.Our charter documents and Delaware law could prevent a takeover that stockholders consider favorable and could also reduce the market price of our stock.Q4, 2023
3.If our acquired intangible assets become impaired in the future, we may incur significant impairment charges.Q4, 2023

Blum Holdings Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

BLMH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AYTUAYTU62Neutral$19.35M-1.30-52.89%―-13.27%27.11%
SNOASNOA54Neutral$5.52M-1.20-36.40%―38.69%58.68%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
YCBDYCBD43Neutral$4.19M-1.22-34.25%―10.01%95.01%
BLMHBLMH39Underperform$4.51M-0.40107.69%―19.98%-180.06%
IMCCIMCC39Underperform$936.11K-0.04528.80%―-35.33%-127.87%
PRFXPRFX37Underperform$2.38M-0.07-72.87%―――

* Healthcare Sector Average

Performance Comparison

-100%0%100%200%BLMHSNOAAYTUYCBDPRFXIMCCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
BLMH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
BLMHBlum Holdings Inc0.14-0.49-77.30%
SNOASonoma Pharmaceuticals, Inc.1.09-2.53-69.89%
AYTUAytu BioScience1.78-0.20-10.10%
YCBDCbdmd INc0.37-0.23-37.67%
PRFXPainreform Ltd.0.78-3.64-82.30%
IMCCIm Cannabis Corp0.57-29.39-98.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 24, 2026